Medicinal product for the promotion of wound healing

Abstract

The invention relates to a medicinal product for topical use for the promotion of wound healing, which comprises thrombocytes or thrombocyte fragments, wherein the thrombocytes or thrombocyte fragments contain growth factors and are capable of releasing the same and are present in the lyophilized or deep-frozen state and have been subjected to a process for virus partitioning and/or virus inactivation.

1 . A medicinal product for topical use for the promotion of wound healing, which comprises thrombocytes or thrombocyte fragments, wherein said thrombocytes or thrombocyte fragments 
 contain growth factors and are capable of releasing the same,    are present in the lyophilized or deep-frozen state, and    have been subjected to a process for virus partitioning and/or virus inactivation.    
     
     
         2 . A medicinal product according to  claim 1 , characterized in that the content of thrombocytes or thrombocyte fragments is such that it corresponds to at least 10 4 , preferably at least 10 5 , thrombocytes per ml after reconstitution of the lyophilisate or thawing.  
     
     
         3 . A medicinal product according to  claim 1  or  2 , characterized in that the medicinal product comprises additional growth factors.  
     
     
         4 . A medicinal product according to any one of  claims 1  to  3 , characterized in that the medicinal product comprises biomaterials.  
     
     
         5 . A medicinal product according to  claim 4 , characterized in that the biomaterials have been subjected to a process for virus partitioning and/or virus inactivation.  
     
     
         6 . A medicinal product according to  claim 4  or  5 , characterized in that the biomaterials are present in the lyophilized or deep-frozen state.  
     
     
         7 . A medicinal product according to any one of  claims 4  to  6 , characterized in that tissue adhesive and/or collagen are provided as biomaterials.  
     
     
         8 . A medicinal product according to  claim 7 , characterized in that the tissue adhesive is composed of fibrinogen-containing proteins and thrombin.  
     
     
         9 . A medicinal product according to any one of  claims 4  to  8 , characterized in that the medicinal product additionally comprises epithelial cells and/or keratinocytes and/or embryonic and/or fetal cells and/or liposomes.  
     
     
         10 . The use of thrombocytes or thrombocyte fragments containing growth factors and capable of releasing the same, for the production of a medicinal product for topical use for the promotion of wound healing.